» Articles » PMID: 33137933

In-House Developed ELISA Indicates High Prevalence of Anti- IgG in Sheep Population-An Update from Pakistan

Abstract

Cystic echinococcosis (CE) is a World Health Organization (WHO)-listed neglected tropical farm economy jeopardizing and public health concern disease. This study was aimed at furnishing sero-epidemiological baseline data of CE in sheep in Pakistan, where data are non-existent. For this purpose, two sheep-rich provinces of Pakistan were selected, and 728 sheep sera were collected using probability proportional to size (PPS) statistical technique. Epidemiological information was recorded on a questionnaire for the estimation of potential risk factors. The serum samples were analyzed for IgG antibodies against using an in-house-developed EgAgB-based ELISA kit. The overall seroprevalence recorded was 21.98% (160/728) in the tested sheep, suggesting higher seropositivity in sheep from Punjab (23.73%) as compared to Khyber Pakhtunkhwa (KPK) (19.04%). The overall apparent prevalence observed by this ELISA method was almost similar to the calculated true prevalence (21.77%). Prevalence was significantly different ( < 0.05) among sheep from different districts. Higher prevalence was found in females (22.54%, OR 1.41), age group > 5 years (29.66%, OR 1.64), crossbreeds (42.85%, OR 2.70), and sheep with pasture access (25.96%, OR 3.06). Being in age group > 5 years and having pasture access were the factors significantly associated with seropositivity ( < 0.05). This study provides serological evidence of . infection in sheep and can be used as a model for screening of the sheep globally.

Citing Articles

Proteomic analysis of mouse liver lesions at all three stages of Echinococcus granulosus infection.

Jiang N, Chen Y, Li T, Sun Y, Su Y, Wang Y PLoS Negl Trop Dis. 2024; 18(12):e0012659.

PMID: 39625960 PMC: 11614251. DOI: 10.1371/journal.pntd.0012659.


Detection of Anti- Antibodies in Humans: An Update from Pakistan.

Khan H, Ahmed H, Afzal M, Awan U, Khurram M, Simsek S Pathogens. 2022; 11(1).

PMID: 35055977 PMC: 8781053. DOI: 10.3390/pathogens11010029.

References
1.
Ibrahem M, Craig P, McVie A, Ersfeld K, Rogan M . Echinococcus granulosus antigen B and seroreactivity in natural ovine hydatidosis. Res Vet Sci. 1996; 61(2):102-6. DOI: 10.1016/s0034-5288(96)90082-x. View

2.
Latif A, Tanveer A, Maqbool A, Siddiqi N, Kyaw-Tanner M, Traub R . Morphological and molecular characterisation of Echinococcus granulosus in livestock and humans in Punjab, Pakistan. Vet Parasitol. 2010; 170(1-2):44-9. DOI: 10.1016/j.vetpar.2010.02.003. View

3.
Brehm K . The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction. Med Microbiol Immunol. 2010; 199(3):247-59. DOI: 10.1007/s00430-010-0154-1. View

4.
Conceicao M, Cravo I, Costa I, Ferreira R, Costa R, Castro A . Echinococcus granulosus ss in dog - A report in center-northern Portugal. Vet Parasitol Reg Stud Reports. 2019; 9:84-87. DOI: 10.1016/j.vprsr.2017.05.002. View

5.
Pourseif M, Moghaddam G, Saeedi N, Barzegari A, Dehghani J, Omidi Y . Current status and future prospective of vaccine development against Echinococcus granulosus. Biologicals. 2017; 51:1-11. DOI: 10.1016/j.biologicals.2017.10.003. View